Data as of Sep 29
| +0.20 / +0.40%|
The 20 analysts offering 12-month price forecasts for ResMed Inc have a median target of 53.03, with a high estimate of 60.81 and a low estimate of 39.00. The median estimate represents a +6.12% increase from the last price of 49.97.
The current consensus among 24 polled investment analysts is to Hold stock in ResMed Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.